Viskase Holdings, Inc. (VISK): Total Assets
$42.81M
As of 2025-12-31
$424.48M
As of 2026-06-30
-3.5%
3-year compound annual growth
-2.4%
5-year compound annual growth
+6.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $42.81M | -9.2% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $47.17M | -1.1% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $47.70M | +0.2% | 2025-02-21, Balance as of period end |
| 2022-12-31 | $47.59M | -0.3% | 2024-03-20, Balance as of period end |
| 2021-12-31 | $47.75M | -1.0% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $48.23M | +644.6% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $6.48M | -58.2% | 2021-02-23, Balance as of period end |
| 2018-12-31 | $15.51M | +63.1% | 2020-02-19, Balance as of period end |
| 2017-12-31 | $9.51M | -15.6% | 2019-02-21, Balance as of period end |
| 2016-12-31 | $11.27M | -50.8% | 2018-03-21, Balance as of period end |
| 2015-12-31 | $22.89M | -34.7% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $35.04M | +392.1% | 2016-03-21, Balance as of period end |
| 2013-12-31 | $7.12M | -96.4% | 2015-03-05, Balance as of period end |
| 2012-12-31 | $199.78M | -41.8% | 2014-03-14, Balance as of period end |
| 2011-12-31 | $343.21M | -29.8% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $488.86M | n/a | 2012-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Viskase Holdings, Inc. (VISK) | 2025-12-31 | $42.81M | -9.2% |
| Ocugen, Inc. (OCGN) | 2025-12-31 | $43.52M | -47.2% |
| PharmaCyte Biotech, Inc. (PMCB) | 2026-04-30 | $46.75M | -15.3% |
| Cognition Therapeutics Inc (CGTX) | 2025-12-31 | $48.39M | +60.1% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $51.22M | -47.6% |
| Jasper Therapeutics, Inc. (JSPR) | 2025-12-31 | $35.78M | -55.2% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $32.35M | -18.2% |
| IN8BIO, Inc. (INAB) | 2025-12-31 | $32.28M | +54.1% |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $59.74M | -41.2% |
Compare VISK, OCGN, PMCB, CGTX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗